Gene expression, purification and characterization of recombinant human neutrophil collagenase. 1994

T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
Department of Molecular Biology, Sterling Winthrop Pharmaceuticals Research Division, Collegeville, PA 19426-0900.

Human neutrophil collagenase (HNC) is a member of a family of matrix metalloproteinases (MMP). HNC is capable of cleaving all three alpha-chains of types I, II and III collagens. In rheumatoid and osteo-arthritis, MMP members have been implicated in the pathology associated with these diseases due to the accelerated breakdown of the extracellular matrix of articular cartilage. A cDNA coding for the HNC catalytic domain (lacking both the propeptide and C-terminal fragments) was sub-cloned into the pETlla prokaryotic expression vector. The cloned fragment encodes a protein that extends from amino acids (aa) Met100 through Gly262 of the full-length proenzyme, which as a result, would not require proteolytic or chemical activation. The HNC construct was expressed in Escherichia coli and recombinant mature, truncated neutrophil collagenase (re-mNC-t) was produced at high levels (approx. 30% of total bacterial protein). The re-mNC-t protein was extracted from inclusion bodies by solubilization in 6 M urea, followed by ion-exchange chromatography. The protein was refolded to an active conformation in the presence of Ca2+ and Zn2+. A final purification step on size-exclusion chromatography yielded 30 mg per liter of active re-mNC-t with minor autodegradative products. Alternatively, hydroxamate affinity chromatography was used to obtain pure, non-degraded re-mNC-t (20-25 mg per liter). The catalytic activity of re-mNC-t was abolished by known MMP inhibitors and the Ki measurement against actinonin was similar to that of HNC prepared from human blood.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017364 Collagenases Enzymes that catalyze the degradation of collagen by acting on the peptide bonds. Collagen Peptidase,Collagen-Degrading Enzyme,Collagenase,Collagen Degrading Enzyme,Peptidase, Collagen
D020784 Matrix Metalloproteinase 8 A member of the MATRIX METALLOPROTEINASES that cleaves triple-helical COLLAGEN types I, II, and III. Collagenase-2,Fibroblast Collagenase,Neutrophil Collagenase,MMP-8 Metalloproteinase,MMP8 Metalloproteinase,Matrix Metalloproteinase-8,Collagenase 2,Collagenase, Fibroblast,Collagenase, Neutrophil,MMP 8 Metalloproteinase,Metalloproteinase 8, Matrix,Metalloproteinase, MMP-8,Metalloproteinase, MMP8,Metalloproteinase-8, Matrix

Related Publications

T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
February 1991, Biochemical Society transactions,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
February 1997, FEBS letters,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
June 1997, Protein expression and purification,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
January 1998, The Biochemical journal,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
September 1996, Protein expression and purification,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
November 1990, Biochemistry,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
August 1997, Protein expression and purification,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
June 1998, Wei sheng wu xue bao = Acta microbiologica Sinica,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
February 2010, Protein expression and purification,
T F Ho, and M W Qoronfleh, and R C Wahl, and T A Pulvino, and K J Vavra, and J Falvo, and T M Banks, and P G Brake, and R B Ciccarelli
November 1997, The Biochemical journal,
Copied contents to your clipboard!